Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 846

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 846
---
 hereby acknowledged, the parties agree as follows:

1.

Assumption of the Obligations . As of and with effect on and from the Closing (as defined in the Combination Agreement), the Company hereby assigns to ParentCo all of the Company’s rights, titles, interests and obligations in and under the Warrant Agreement; and ParentCo hereby assumes, and agrees to pay, perform, satisfy and discharge in full, as the same become due, all of the Company’s liabilities and obligations under the Warrant Agreement arising on, from and after the Closing.

2.

Consent . The Warrant Agent hereby consents to (i) the assignment of the Warrant Agreement by the Company to ParentCo and the assumption of the Warrant Agreement by ParentCo from the Company, in each case effective as of the Closing, and (ii) the continuation of the Warrant Agreement, in full force and effect from and after the Closing.

<div align='center'>J-1</div>

TABLE OF CONTENTS

3.

No Amendments . Except for the assumption of the Obligations by ParentCo hereunder, the Warrant Agreement shall remain unchanged and in full force and effect.

4. Miscellaneous .

(a)

The Company and ParentCo agree to execute such reasonable further instruments or perform such reasonable acts which are or may become reasonably necessary to carry out the intent of this Agreement.

(b)

This Agreement shall be governed by and construed under the laws of the State of New York without regard to its conflict of laws principles.

(c)

This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.

<div align='center'>[ The balance of this page is intentionally left blank. ]

J-2</div>

TABLE OF CONTENTS

IN WITNESS WHEREOF, the parties have executed this Agreement as of the date first above written.

IRIS ACQUISITION CORP.

By:

Name: Sumit Mehta

Title: Chief Executive Officer

IRIS PARENT HOLDING CORP.

By:

Name: Chris Kim

Title: CEO, Secretary, and Treasurer

CONTINENTAL STOCK TRANSFER & TRUST COMPANY, as Warrant Agent

By:

Name:

Title:

<div align='center'>J-3</div>

TABLE OF CONTENTS

#### Annex K
2025IRIS ACQUISITION CORPPLEASE DO NOT RETURN THE PROXY CARDIF YOU ARE VOTING ELECTRONICALLY.INTERN